Specifically, a recent study identified that MAFG-driven astrocytes promote CNS inflammation and repress antioxidant and anti-inflammatory transcriptional modules in MS and its preclinical model, experimental autoimmune encephalomyelitis (EAE) (Wheeler et al., 2020). This evidence concerns the gene MAFG and myeloid sarcoma.